Supernus Pharmaceuticals Inc Net Asset Quality Index
Supernus Pharmaceuticals Inc net asset quality index. Supernus Pharmaceuticals Inc (SUPN) has a Net Asset Quality Index of 72.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.43 Billion minus total liabilities of $396.88 Million yields net assets of $1.03 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SUPN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Supernus Pharmaceuticals Inc (2008–2025)
Net asset quality index of Supernus Pharmaceuticals Inc from 2008 to 2025. This chart shows how Supernus Pharmaceuticals Inc's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 72.2%, representing net assets of $1.03 Billion against total assets of $1.43 Billion USD. See SUPN book value for net asset value and shareholders' equity analysis.
Supernus Pharmaceuticals Inc Net Asset Quality Index by Year (2008–2025)
Supernus Pharmaceuticals Inc net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Supernus Pharmaceuticals Inc from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Supernus Pharmaceuticals Inc (SUPN) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.1% | $1.06 Billion | $1.45 Billion | $390.93 Million | ▼ -2.6 pp |
| 2024 | 75.7% | $1.04 Billion | $1.37 Billion | $332.34 Million | ▲ +3.6 pp |
| 2023 | 72.1% | $921.52 Million | $1.28 Billion | $356.16 Million | ▲ +20.1 pp |
| 2022 | 52.1% | $886.20 Million | $1.70 Billion | $816.30 Million | ▲ +3.8 pp |
| 2021 | 48.3% | $815.85 Million | $1.69 Billion | $873.30 Million | ▼ -1.2 pp |
| 2020 | 49.5% | $744.86 Million | $1.50 Billion | $759.24 Million | ▼ -1.8 pp |
| 2019 | 51.3% | $595.43 Million | $1.16 Billion | $564.85 Million | ▲ +5.0 pp |
| 2018 | 46.3% | $453.02 Million | $977.81 Million | $524.79 Million | ▼ -16.7 pp |
| 2017 | 63.0% | $267.48 Million | $424.46 Million | $156.98 Million | ▲ +1.1 pp |
| 2016 | 61.9% | $191.75 Million | $309.57 Million | $117.81 Million | ▼ -1.0 pp |
| 2015 | 63.0% | $118.88 Million | $188.73 Million | $69.86 Million | ▲ +11.1 pp |
| 2014 | 51.9% | $71.35 Million | $137.51 Million | $66.15 Million | ▲ +21.7 pp |
| 2013 | 30.1% | $33.46 Million | $111.00 Million | $77.53 Million | ▼ -31.1 pp |
| 2012 | 61.3% | $57.57 Million | $93.99 Million | $36.42 Million | ▲ +43.7 pp |
| 2011 | 17.6% | $9.44 Million | $53.73 Million | $44.29 Million | ▲ +111.9 pp |
| 2010 | -94.3% | $-44.32 Million | $47.01 Million | $91.33 Million | ▼ -86.6 pp |
| 2009 | -7.7% | $-6.16 Million | $79.90 Million | $86.06 Million | ▲ +1.0 pp |
| 2008 | -8.7% | $-6.75 Million | $77.13 Million | $83.88 Million | — |